Singapore markets closed

Tandem Diabetes Care, Inc. (0M0F.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
37.61+0.11 (+0.28%)
At close: 05:39PM BST
Full screen
Previous close37.50
Open36.36
Bid0.00 x N/A
Ask0.00 x N/A
Day's range36.36 - 37.93
52-week range13.89 - 43.04
Volume112
Avg. volume681
Market cap21.291M
Beta (5Y monthly)1.13
PE ratio (TTM)4.23
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Tandem Diabetes Care Announces Upcoming Conference Presentations

    SAN DIEGO, April 29, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

  • Business Wire

    Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024

    SAN DIEGO, April 09, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.

  • GlobeNewswire

    Parexel Announces CEO Succession Plan

    Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced that Jamie Macdonald will retire and transition his role as Chief Executive Officer (CEO) to the c